Riskpilot← Back to searchSign inGet full accessSCOPHELP AS
ASActiveOrg 922025428Hoppern 15, 1517 MossMedical specialists activities · NACE 8622Est. 20195 employees
Revenue 2024
NOK 7M
+89% vs 2023
EBITDA margin
16.6%
-37% vs 2023
Equity ratio
29.2%
Financial strength
Net profit 2024
NOK 236K
-80% vs 2023
| Revenue | NOK 7M | +89% |
| EBITDA | NOK 1,2M | -37% |
| Net profit | NOK 236K | -80% |
| Total assets | NOK 3,9M | -11% |
| Equity | NOK 1,1M | +0% |
| Employees | 5 | — |
Legal name
SCOPHELP AS
Org number
922025428
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
8. januar 2019
Share capital
NOK 30 000
Employees
5 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Organisering av spesialpraksis for leger innen allmenn-, indremedisin og fordøyelsessykdommer, eiendom og andre produkter/tjenester som naturlig hører sammen med dette, herunder å delta i andre selskap med lignende virksomhet, kjøp og salg av aksjer eller på annen måte gjøre seg interessert i andre foretak.
Address
Hoppern 15, 1517 Moss
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 238 | 218 | 11 | 3 694 | 6 999 |
| Staff expenses | −200 | −234 | −0 | −942 | −2 955 |
| EBITDA | 31 | −87 | −12 | 1 849 | 1 163 |
| Depreciation & amort. | −0 | −0 | −0 | −371 | −808 |
| EBIT | 31 | −87 | −12 | 1 477 | 356 |
| Net financials | 0 | −0 | −30 | 73 | −51 |
| Profit before tax | 31 | −87 | −42 | 1 550 | 305 |
| Tax | 7 | −19 | −9 | 341 | 68 |
| Net profit | 24 | −68 | −33 | 1 209 | 236 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 274 | 70 | 34 | 4 388 | 3 918 |
| Equity | 31 | −37 | −70 | 1 139 | 1 145 |
| Long-term debt | 0 | 0 | 0 | 79 | 30 |
| Short-term debt | 242 | 107 | 104 | 3 170 | 2 744 |
| Total debt | 243 | 107 | 104 | 3 249 | 2 773 |
EBITDA margin
16.6%
This company
15.8%
Market median
+5% vs market
20202024
Equity ratio
29.2%
This company
38.2%
Market median
-24% vs market
20202024
Return on equity
20.6%
This company
18.4%
Market median
+12% vs market
20202024
Net profit margin
3.4%
This company
8.1%
Market median
-58% vs market
20202024
Asset turnover
1.79×
This company
1.12×
Market median
+60% vs market
20202024
Debt / equity
2.42×
This company
0.62×
Market median
-290% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2019 | |
| Chairman | 2019 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 50% | 50% | 2022 | |
| Company | 50% | 50% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Gardini As
SCOPHELP AS Board members of SCOPHELP AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Badboni El-Safadi | Board of Directors | 0 companies |
| Rogelio Oswaldo Barreto Rios | Chairman | 0 companies |